Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
Research on immunization discussed by H.W. Chesson and co-researchers
March 25th, 2008
According to recent research published in the journal Emerging Infectious Diseases, "We describe a simplified model, based on the current economic and health effects of human papillornavirus (HPV), to estimate the cost-effectiveness of HPV vaccination of 12-year-old girls in the United States." "Under base-case parameter values, the estimated cost per quality-adjusted life year gained by vaccination in the context of current cervical cancer screening practices in the United States ranged from $3,906 to $14,723 (2005 US dollars), depending on factors such as whether herd immunity effects were assumed; the types of HPV targeted by the vaccine; and whether the...
Source: Cancer Weekly (2008-03-25)
|
